𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line

✍ Scribed by Eizo Kimura; Stephen B. Howell


Publisher
Springer
Year
1993
Tongue
English
Weight
627 KB
Volume
32
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Comparative cytotoxicity of CI-973, cisp
✍ R. P. Perez; P. J. O'Dwyer; L. M. Handel; R. F. Ozols; T. C. Hamilton 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract The clinical efficacy of cisplatin‐based chemotherapy for ovarian cancer is frequently compromised by drug resistance or dose‐limiting renal and neurologic toxicities. CI‐973 (NK‐121), a 2‐methyl‐1, 4‐butanediamine analogue of carboplatin, has shown little nephro‐and neuro‐toxicity in p

Mechanism of interaction between cisplat
✍ Alissar Nehmé; Nicolas Albin; Marie Josée Caliaro; Sylvie Guichard; Suzanne Joza 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 857 KB

## Abstract Human ovarian carcinoma cells (2008 and its cisplatin‐resistant sub‐line 2008/C13\*) were sensitized to cisplatin by treatment with human recombinant gamma interferon (IFNγ). IFNγ produced no significant change in the uptake of CDDP. Exposure of 2008 and 2008/C13\* cells to IFNγ resulte

Altered adhesion properties and alpha v
✍ Sylvie Maubant; Séverine Cruet-Hennequart; Laurent Poulain; Franck Carreiras; Fr 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 416 KB

## Abstract In order to elucidate the mechanisms underlying the development of chemoresistance in ovarian cancer, we have previously established the IGROV1‐R10 cisplatin‐resistant cell line by mimicking a clinical protocol of drug administration on IGROV1 human ovarian carcinoma cells. Both IGROV1

Effect of novobiocin on cisplatin cytoto
✍ Steven De Jong; Hetty Timmer-Bosscha; Elisabeth G. E. De Vries; Nanno H. Mulder 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 948 KB

## Abstract Studies were performed to determine whether novobiocin can be used to enhance cisplatin (CDDP) cytotoxicity in a human small‐cell lung carcinoma cell line, GLC~4~/CDDP, resistant to CDDP. Continuous incubation with novobiocin enhanced the cytotoxicity of CDDP treatment 1.9‐fold in the p